EIGHT-year-old leukemia patient Goh Ting Haw requires about RM800,000 to undergo Chimeric Antigen Receptor (CAR T-Cell) treatment in Singapore.
Ting Haw’s family is seeking public funding for the treatment which offers a recovery rate of over 60%.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!